Pulmonary & Sleep Medicine Research
Reliance Study
Roflumilast or Azithromycin to Prevent COPD Exacerbations
Age: 40 years and older
Sex at Birth: All
Sex at Birth: All
Type: Interventional Study
Condition: Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Healthy Participants: Yes
Location: UH Cleveland Medical Center
Location: UH Cleveland Medical Center
Learn More About This Research Study
For more information, please contact Mario Becerra, RN at 216-844-1734 or complete the online form below.
Study Purpose
The purpose of this study is to compare two drugs, Azithromycin or Roflumilast, that doctors are planning to prescribe for their patients with Chronic Obstructive Pulmonary Disease.
Who Can Participate
Participants 40 years or older diagnosed with Chronic Obstructive Pulmonary Disease whose physician plans to presecribe Azithromycin or Roflumilast may be eligible for this study.
- STUDY20180374
- NCT04069312